Immuneering Overview
Immuneering Discounted Cash Flow
DCF Analysis for IMRX.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.84
Current Fair Value
$2.84
↓ 32.3% Downside
Overvalued by 32.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison